Protagen Protein Services GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Protagen Protein Services GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11289
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Protagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co KG is a contract research organization that offers protein analytics. The organization offers services such as services for biopharmaceuticals, protein characterization, biosimilars services, and analytical methods, among others. Its protein characterization services include protein modification, bioassay, protein quantification, protein primary structure, and protein impurities. PPS’s services for biosimilars comprise detailed structural characterization and support in cell line and process development, among others. The organization partners with research institutes to offer its services to clients. It works in partnership with other research institutions and pharmaceutical companies. PPS is headquartered in Heilbronn, Germany.

Protagen Protein Services GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 9
Merger 10
Protagen Protein Services Merges with Panatecs 10
Acquisition 11
Zukunftsfonds Heilbronn Acquires Protagen Protein Services From Protagen 11
Protagen Protein Services GmbH – Key Competitors 12
Protagen Protein Services GmbH – Key Employees 13
Protagen Protein Services GmbH – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 9
Protagen Protein Services Merges with Panatecs 10
Zukunftsfonds Heilbronn Acquires Protagen Protein Services From Protagen 11
Protagen Protein Services GmbH, Key Competitors 12
Protagen Protein Services GmbH, Key Employees 13
Protagen Protein Services GmbH, Other Locations 14

List of Figures
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Protagen Protein Services GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SunOpta Inc.:企業のM&A・事業提携・投資動向
    SunOpta Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SunOpta Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Subaru Corporation (7270):企業の財務・戦略的SWOT分析
    Subaru Corporation (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Steris PLC:戦略・SWOT・企業財務分析
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bank of China Ltd:戦略・SWOT・企業財務分析
    Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • KKR & Co. L.P.:企業の戦略・SWOT・財務情報
    KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Idemitsu Kosan Co Ltd (5019)-エネルギー分野:企業M&A・提携分析
    Summary Idemitsu Kosan Co., Ltd. (Idemitsu) is an integrated energy company that explores, produces, refines, and sells oil and gas, lubricants, and petroleum products. Apart from petroleum products, the company also manufactures agricultural chemicals, agricultural materials, and other chemicals. I …
  • Fog Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fog Pharmaceuticals Inc (Fog Pharmaceuticals) is a clinical-stage biotechnology company that discovers and develops next-generation peptide inhibitors that target traditionally undruggable intracellular protein-protein interactions. The company develops cell-penetrating miniproteins (CPMPs), …
  • Al Waha Capital P.J.S.C.:企業の戦略・SWOT・財務情報
    Al Waha Capital P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Al Waha Capital P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Torrent Power Ltd (TORNTPOWER):電力:M&Aディール及び事業提携情報
    Summary Torrent Power Limited (Torrent Power), a subsidiary of Torrent Group is a power utility that generates, transmits and distributes electricity. The company generates electricity through coal based, gas based and renewable power plants. It distributes power to residential, commercial and indus …
  • Dyadic International Inc (DYAI):企業の財務・戦略的SWOT分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops, discovers, manufactures, and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila expression systems to conduct research and produce industrial en …
  • Solaris Oilfield Infrastructure Inc (SOI):石油・ガス:M&Aディール及び事業提携情報
    Summary Solaris Oilfield Infrastructure Inc (Solaris) is a provider of supply chain management and logistics solutions for oil and natural gas industry. The company manufactures and provides mobile proppant management systems that unload, store and deliver proppant at oil and natural gas well sites …
  • PT ANTAM (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Morphogenesis Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Morphogenesis Inc (Morphogenesis) is a developer of novel cell and gene therapies to detect, monitor and control cancer. The company manufactures products based on distinct and synergistic technology platforms. It uses technologies such as immunefx cancer immunotherapies, the polymer antibod …
  • Atlas Energy Group LLC:企業の戦略・SWOT・財務情報
    Atlas Energy Group LLC - Strategy, SWOT and Corporate Finance Report Summary Atlas Energy Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • JA Solar Holdings Co Ltd (JASO):電力:M&Aディール及び事業提携情報
    Summary JA Solar Holdings Co Ltd (JA Solar) is a developer and provider of solar photovoltaic products. The company designs, develops, manufactures and sells silicon wafers, solar cells and solar modules. It offers both monocrystalline and mulicrystalline solar cells and modules. JA Solar also provi …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • Icagen Inc:企業のM&A・事業提携・投資動向
    Icagen Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icagen Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • ICON Plc (ICLR)-製薬・医療分野:企業M&A・提携分析
    Summary ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company …
  • Aprima Medical Software Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aprima Medical Software Inc (Aprima) is a healthcare information technology service provider. The company’s solutions include EHR, practice management, and revenue cycle management. Its EHR solutions provide patient engagement, mobility, clinical decision support, integrated inbound and outb …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆